EUVIMEDEUVIMED entdecken
Crossref

SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis

Ti Zhou, Lianqiang Shen, Yao Ma, Shaowei Mo, Haibin Lan, Shan Gao

Biochemical and Biophysical Research Communications · 2026-09 · 830 · 154242

DOI: 10.1016/j.bbrc.2026.154242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Ti Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First People's Hospital of Linping District, Hangzhou, 311100, China. Electronic address: zhouti_fmmu@163.com. Hauptthemen laut MEDLINE: Sorafenib, Ferroptosis, Carcinoma, Hepatocellular, Drug Resistance, Neoplasm. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Acquired resistance to sorafenib remains a major obstacle to effectively treating advanced hepatocellular carcinoma (HCC). Ferroptosis has emerged as a key mechanism influencing therapeutic response. EGF-containing fibulin extracellular matrix protein 1 (EFEMP1) contributes to sorafenib resistance in HCC cells by regulating ferroptosis, but its upstream regulatory mechanisms remain elusive. METHODS Potential E3 ligases for EFEMP1 were screened using the UbiBrowser database. Protein interactions were validated by co-immunoprecipitation. The effects of SMAD ubiquitination regulatory factor 1 (SMURF1) and EFEMP1 on sorafenib sensitivity were assessed via IC50, colony formation, apoptosis, and migration/invasion assays. Assessment of ferroptosis was based on measuring levels of ROS, MDA, and iron, along with the expression of SLC7A11 and GPX4. The in vivo efficacy was demonstrated employing a xenograft mouse model. RESULTS SMURF1 could bind to and ubiquitinate EFEMP1, promoting its proteasomal degradation. Overexpression of SMURF1 in sorafenib-resistant HCC cells decreased EFEMP1 protein stability, reversed drug resistance, and suppressed malignant phenotypes, but these effects were rescued following EFEMP1 upregulation. Mechanistically, SMURF1-mediated EFEMP1 degradation activated ferroptosis, evidenced by increased ROS/MDA/iron and decreased SLC7A11/GPX4, which was also reversed by EFEMP1. In vivo, SMURF1 overexpression synergized with sorafenib to inhibit tumor growth, which was again reversed by EFEMP1. CONCLUSION This study demonstrates a novel SMURF1-EFEMP1-ferroptosis regulatory axis, wherein SMURF1 overcomes sorafenib resistance by ubiquitinating and degrading EFEMP1 to relieve its inhibition on ferroptosis. Targeting this axis presents a promising strategy for combating acquired resistance in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibFerroptosisCarcinoma, HepatocellularDrug Resistance, NeoplasmLiver NeoplasmsUbiquitin-Protein LigasesExtracellular Matrix ProteinsHumansUbiquitinationAnimalsMiceCell Line, TumorAntineoplastic AgentsMice, Nude

Stichwörter der Autor:innen

EFEMP1FerroptosisHepatocellular carcinomaSMURF1SorafenibUbiquitination

Substanzen

SorafenibUbiquitin-Protein LigasesExtracellular Matrix ProteinsEFEMP1 protein, humanSMURF1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of General Surgery, The First People's Hospital of Linping District, Hangzhou, 311100, China. Electronic address: zhouti_fmmu@163.com.
  • Department of General Surgery, The First People's Hospital of Linping District, Hangzhou, 311100, China. Electronic address: shenlianqiang@126.com.
  • Department of General Surgery, The First People's Hospital of Linping District, Hangzhou, 311100, China. Electronic address: 709762180@qq.com.
  • Department of General Surgery, The First People's Hospital of Linping District, Hangzhou, 311100, China. Electronic address: 201811112511317@zcmu.edu.cn.
  • Department of General Surgery, The First People's Hospital of Linping District, Hangzhou, 311100, China. Electronic address: haibinbule@163.com.
  • Department of General Surgery, The First People's Hospital of Linping District, Hangzhou, 311100, China. Electronic address: drgaoshan@126.com.

Zitieren

APA

Zhou, T., Shen, L., Ma, Y., Mo, S., Lan, H., & Gao, S. (2026). SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis. Biochemical and Biophysical Research Communications, 830, 154242. https://doi.org/10.1016/j.bbrc.2026.154242

Vancouver

Zhou T, Shen L, Ma Y, Mo S, Lan H, Gao S. SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis. Biochemical and Biophysical Research Communications. 2026;830:154242. doi:10.1016/j.bbrc.2026.154242

BibTeX
@article{Zhou2026,
  author = {Zhou, Ti and Shen, Lianqiang and Ma, Yao and Mo, Shaowei and Lan, Haibin and Gao, Shan},
  title = {SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {830},
  pages = {154242},
  doi = {10.1016/j.bbrc.2026.154242}
}
Kostenlos starten →